26m
Zacks Investment Research on MSNNovo Nordisk Lowers Wegovy Costs for Cash-Pay Patients, Stock Up 4%Novo Nordisk NVO announced that it is launching a new direct-to-patient online pharmacy called NovoCare, which will offer its ...
In an exclusive conversation with Business Today, Camilla Sylvest, Executive Vice President, Commercial Strategy & Corporate ...
Danish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for all doses of Wegovy. The new monthly price of ...
Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision ...
Over 31 million Americans borrowed a collective $74 billion to pay for healthcare last year, a West Health-Gallup survey ...
Dear Annie: I’ve known my friend “Ella” for over 50 years. In the last few years, for whatever reason, she only wants to ...
One of the few drug developers based in Worcester is leaving Wormtown for Waltham. Also, Novo Nordisk and Eli Lilly have ...
As a federal court in Texas hears a case pitting the FDA versus compounders who want to continue to manufacture cheaper ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Novo Nordisk (NVO – Research Report) and Veeva Systems (VEEV ...
Italian hearing aid company Amplifon reported an annual core profit margin of 23.6% on Thursday, short of its revised ...
U.S. taxpayers spent billions developing Ozempic-type diabetes and weight-loss drugs — now those drugs’ markups could ...
Novo Nordisk (NVO) plans to study how its GLP-1 drugs marketed as Wegovy and Ozempic for obesity and diabetes can help tackle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results